Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 219

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular Risk

Rosano, Giuseppe M.C., Aversa, Antonio, Vitale, Cristiana, Fabbri, Andrea, Fini, Massimo, Spera, Giovanni·2005·European Urology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.eururo.2004.10.002

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 43

  1. Flavahan, 1992, Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity, Circulation, 85, 1927, 10.1161/01.CIR.85.5.1927 · DOI
  2. Ross, 1993, The pathogenesis of atherosclerosis: a perspective for 1990s, Nature, 362, 801, 10.1038/362801a0 · DOI · Paper page
  3. Panza, 1990, Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension, N Engl J Med, 323, 22, 10.1056/NEJM199007053230105 · DOI · Paper page
  4. Schächinger, 2000, Prognostic Impact of Coronary Vasodilator Dysfunction on Adverse Long-Term Outcome of Coronary Heart Disease, Circulation, 101, 1899, 10.1161/01.CIR.101.16.1899 · DOI
  5. Sorensen, 1995, Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility, Br Heart J, 74, 247, 10.1136/hrt.74.3.247 · DOI · Paper page
  6. Kloner RA, Speakman M. Erectile Dysfunction and Atherosclerosis Current Atherosclerosis reports 2002;4:397–401. · DOI
  7. Soloman, 2003, Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator, Heart, 89, 251, 10.1136/heart.89.3.251 · DOI
  8. Rosen, 1991, Cigarette smoking: an independent risk factor for atherosclerosis in the hypogastric-cavernous arterial bed of men with atherogenic impotence, J Urol, 145, 759, 10.1016/S0022-5347(17)38444-6 · DOI
  9. Aversa, 2004, Erectile dysfunction: expectations beyond phosphodiesterase type-5 inhibition, J Endocrinol Invest, 27, 192, 10.1007/BF03346268 · DOI
  10. Brock, 2002, Efficacy and safety of tadalafil in the treatment of erectile dysfunction: results of integrated analyses, J Urol, 168, 1332, 10.1016/S0022-5347(05)64442-4 · DOI · Paper page
  11. Desouza, 2002, Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes, Diabetes Care, 25, 1336, 10.2337/diacare.25.8.1336 · DOI
  12. Gillies, 2002, Coronary and systemic hemodynamic effects of Sildenafil citrate: from basic science to clinical studies in patients with cardiovascular disease, Int J Cardiol, 86, 131, 10.1016/S0167-5273(02)00421-7 · DOI
  13. De Backer, 2003, European guidelines on cardiovascular disease prevention in clinical practice, Eur J Cardiovasc Prevent Rehabil, 10, S1, 10.1097/00149831-200308000-00004 · DOI · Paper page
  14. Kloner, 2003, Time course of the interaction between tadalafil and nitrates, J Am Coll Cardiol, 42, 1855, 10.1016/j.jacc.2003.09.023 · DOI
  15. Vitale, 2001, Effect of estradiol valerate alone or in association with cyproterone acetate upon vascular function of postmenopausal women at increased risk for cardiovascular disease, Maturitas, 40, 239, 10.1016/S0378-5122(01)00242-0 · DOI
  16. Kukreja, 2004, Cardioprotection with phospodiesterase-5 inhibition a novel preconditioning strategy, J Mol Cell Cardiol, 36, 165, 10.1016/j.yjmcc.2003.11.001 · DOI
  17. Kukreja, 2003, Sildenafil-induced cardioprotection in rabbits, Circ Res, 60, 700
  18. Bhagat, 1997, Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo, circulation, 96, 3042, 10.1161/01.CIR.96.9.3042 · DOI · Paper page
  19. Ross, 1999, Atherosclerosis-an inflammatory disease, N Engl J Med, 340, 115, 10.1056/NEJM199901143400207 · DOI · Paper page
  20. Kaiser, 2004, Impaired brachial artery, endothelium dependent and independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease, J Am Coll Cardiol, 43, 179, 10.1016/j.jacc.2003.07.042 · DOI
  21. Shamloul, 2004, Correlation between penile Duplex findings and and stress electrocardiography in men with erectile dysfunction, Int J Impotence Res, 16, 235, 10.1038/sj.ijir.3901148 · DOI
  22. Montorsi, 2003, Erectile dysfunction prevalence, time of onset and association with risk factors in 300 consecutive patients with acute chest pain and angiographically documented coronary artery disease, Eur Urol, 44, 360, 10.1016/S0302-2838(03)00305-1 · DOI · Paper page
  23. Kim, 2001, Potential predictors of asymptomatic ischemic heart disease in patients with vasculogenic erectile dysfunction, Urology, 58, 441, 10.1016/S0090-4295(01)01210-9 · DOI
  24. Kawanishi, 2001, Screening of ischemic heart disease with cavernous artery blood flow in erectile dysfunction patients, Int J Impot Res, 13, 100, 10.1038/sj.ijir.3900642 · DOI
  25. Weimann, 2000, Sildenafil is a pulmonary vasodilator in awake lambs with acute pulmonary hypertension, Anesthesiology, 92, 1702, 10.1097/00000542-200006000-00030 · DOI
  26. Abrams, 2000, Sildenafil as a selective pulmonary vasodilator in childhood primary pulmonary hypertension, Heart, 84, E4, 10.1136/heart.84.2.e4 · DOI
  27. Zhao, 2001, Sildenafil inhibits hypoxia-induced pulmonary hypertension, Circulation, 104, 424, 10.1161/hc2901.093117 · DOI · Paper page
  28. Wilkens, 2001, Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension, Circulation, 104, 1218, 10.1161/hc3601.096826 · DOI
  29. Wagner, 2003, Modulation of circulating endothelin-1 and big endothelin by nitric oxide inhalation following left ventricular assist device implantation, Circulation, 108, II278
  30. Becker, 2001, Systemic and cavernous plasma levels of endothelin (1–21) during different penile conditions in healthy males and patients with erectile dysfunction, World J Urol, 19, 267, 10.1007/s003450100213 · DOI
  31. Francavilla, 1997, Endothelin-1 in diabetic and nondiabetic men with erectile dysfunction, J Urol, 158, 1770, 10.1016/S0022-5347(01)64125-9 · DOI
  32. Kim, 2002, Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction, J Androl, 23, 76, 10.1002/jand.2002.23.1.76 · DOI
  33. Wingard, 2003, RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum, Am J Physiol Regul Integr Comp Physiol, 285, R1145, 10.1152/ajpregu.00329.2003 · DOI
  34. Matsumura, 2001, Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery, Clin Exp Pharmacol Physiol, 28, 540, 10.1046/j.1440-1681.2001.03484.x · DOI
  35. Bivalacqua, 2003, Endothelial dysfunction in erectile dysfunction: role of the endothelium in erectile physiology and disease, J Androl, 24, S17, 10.1002/j.1939-4640.2003.tb02743.x · DOI · Paper page
  36. Soloman, 2003, Erectile dysfunction and the cardiovascular patient: endothelial dysfunction is the common denominator, Heart, 89, 251, 10.1136/heart.89.3.251 · DOI
  37. Kaiser, 2004, Impaired brachial artery, endothelium dependent and independent vasodilatation in men with erectile dysfunction and no other clinical cardiovascular disease, J Am Coll Cardiol, 43, 179, 10.1016/j.jacc.2003.07.042 · DOI
  38. Hale, 2003, Time course of vascular structural changes during and after short-term antihypertensive treatment, Hypertension, 42, 171, 10.1161/01.HYP.0000079309.68998.65 · DOI
  39. Dishy, 2004, Sildenafil does not improve nitric oxide-mediated endothelium-dependent vascular responses in smokers, Br J Clin Pharmacol, 57, 209, 10.1046/j.1365-2125.2003.01974.x · DOI
  40. Desouza, 2002, Acute and prolonged effects of sildenafil on brachial artery flow-mediated dilatation in type 2 diabetes, Diabetes care, 25, 1336, 10.2337/diacare.25.8.1336 · DOI
  41. Prost, 2003, Efficacy of Tadalafil for the treatment of erectile dysfunction at 24 and 36hours after dosing: a randomised trial, Urol, 62, 121, 10.1016/S0090-4295(03)00359-5 · DOI · Paper page
  42. Siroky, 2003, Vasculogenic erectile dysfunction: newer therapeutic strategies, J Urology, 170, S24, 10.1097/01.ju.0000075361.35942.17 · DOI
  43. Siroky, 2004, Effect of chronic ischemia on constituitive and inducible nitric oxide synthase expression in erectile tissue, J Androl, 25, 382, 10.1002/j.1939-4640.2004.tb02804.x · DOI

Cited by

See all 219

Metadata

Authors
Rosano, G. M. C., Aversa, A., Vitale, C., Fabbri, A., Fini, M., & Spera, G.
Venue
European Urology
Publisher
Elsevier BV
Published
2005-02
Volume
47
Issue
2
Pages
214-222
ISSN
0302-2838
Cited by
219
References
2
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular Risk. https://app.cochat.ai/papers/10.1016/j.eururo.2004.10.002
The paper
Rosano, G. M. C., Aversa, A., Vitale, C., Fabbri, A., Fini, M., & Spera, G. (2005). Chronic Treatment with Tadalafil Improves Endothelial Function in Men with Increased Cardiovascular Risk. European Urology. https://doi.org/10.1016/j.eururo.2004.10.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.